Sarepta reports one death after patient received DMD gene therapy Elevidys
One patient with Duchenne muscular dystrophy has passed away following treatment with Sarepta Therapeutics’ gene therapy Elevidys, the biotech said Tuesday.
One patient with Duchenne muscular dystrophy has passed away following treatment with Sarepta Therapeutics’ gene therapy Elevidys, the biotech said Tuesday.
